AI assistant
IRADIMED CORP — Director's Dealing 2019
Dec 12, 2019
32324_dirs_2019-12-11_22df0c3b-b263-4415-b0d7-7d4b8bb665b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2019-12-09
Reporting Person: JOHNSON BRENT (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-09 | Common Stock | A | 6000 | $0.93 | Acquired | 8112 | Direct |
| 2019-12-09 | Common Stock | S | 6000 | $22.53 | Disposed | 2112 | Direct |
| 2019-12-10 | Common Stock | A | 6000 | $0.93 | Acquired | 8112 | Direct |
| 2019-12-10 | Common Stock | S | 6000 | $22.48 | Disposed | 2112 | Direct |
| 2019-12-11 | Common Stock | A | 4300 | $0.93 | Acquired | 6412 | Direct |
| 2019-12-11 | Common Stock | S | 4300 | $23 | Disposed | 2112 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-09 | Stock Option (Right to Buy) | $0.93 | M | 6000 | Disposed | 2022-11-01 | Common Stock (6000) | Direct |
| 2019-12-10 | Stock Option (Right to Buy) | $0.93 | M | 6000 | Disposed | 2022-11-01 | Common Stock (6000) | Direct |
| 2019-12-11 | Stock Option (Right to Buy) | $0.93 | M | 4300 | Disposed | 2022-11-01 | Common Stock (4300) | Direct |
Footnotes
F1: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.
F2: This transaction was executed in multiple trades at prices ranging from $22.31 to $22.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $22.45 to $22.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.